Maxim Group Downgrades ContraVir Pharma (CTRV) to Hold Mar 20, 2019 07:39AM
ContraVir Pharma (CTRV) Announces Update to Business Activities Aug 6, 2018 03:34PM
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives Aug 6, 2018 03:30PM
Maxim Group Upgrades ContraVir Pharma (CTRV) to Buy Jul 10, 2018 07:33AM
ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering Jun 29, 2018 08:00AM


Jun 12, 2018 12:17PM ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
Jun 5, 2018 09:00AM ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Feb 13, 2018 12:21PM UPDATE: Maxim Group Downgrades ContraVir Pharma (CTRV) at Hold
May 1, 2017 05:01PM ContraVir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Warrants
Apr 25, 2017 09:03AM ContraVir Pharma (CTRV) Prices Shares/Warrant Offering at $1
Apr 25, 2017 09:00AM ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
Apr 20, 2017 09:29AM Pre-Open Movers 04/20: (IMNP) (SCSS) (KCG) Higher; (PLXS) (WR) (PM) Lower (more...)
Feb 14, 2017 08:45AM Maxim Group Reiterates Buy Rating and $4 PT on ContraVir Pharmaceuticals (CTRV); HBV Data at Upcoming Conference
Oct 14, 2016 12:48PM Unusual 11 Mid-Day Movers 10/14: (CTRV) (FBMS) (MGT) Higher; (OPTT) (TAYD) (BIOC) Lower
May 31, 2016 12:24PM ContraVir Pharma (CTRV) Gains Key Preclinical Antiviral Asset with Ciclofilin Pharna Deal; Maxim Affirms at 'Buy'
May 6, 2016 10:17AM Notable Analyst Rating Changes 5/6: (ARIA) (MAC) (GM) Upgraded; (FRT) (WMB) (ZTS) Downgraded
May 5, 2016 05:07PM Maxim Group Starts ContraVir Pharma (CTRV) at Buy